publication venue for Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.. 14:-. 2026 TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease.. 14:-. 2025
